Comparison of risk stratification by OncotypeDX versus HOXB13/IL17BR index and molecular grade index in 166 estrogen receptor positive patients from multiple institutions

被引:0
|
作者
Sgroi, D.
Goss, P.
Steffel, L.
Lester, S.
Brock, J.
Hameed, O.
Hattab, E.
Ma, X-J
Erlander, M.
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Univ Alabama, Birmingham, AL USA
[4] Indiana Univ, Indianapolis, IN 46204 USA
[5] AviaraDx, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:127S / 127S
页数:1
相关论文
共 21 条
  • [21] Prediction of benefit from endocrine therapy in ER plus early stage breast cancer: Correlative studies of the breast cancer index HoxB13/IL17BR (H/I) ratio, ER, PR, and HER2 expression in the randomized Stockholm trial
    Zhang, Yi
    Schroeder, Brock E.
    Jannok, Piiha-Lotta Jerevall
    Fornander, Tommy
    Stal, Olle
    Schnabel, Catherine A.
    Sgroi, Dennis C.
    CANCER RESEARCH, 2015, 75